Articles from BIOTECH Patent News (December 1, 2005)

Title	Author	Type	Words
454 Life Sciences initiates collaborative research agreement with the Broad Institute to facilitate disease-related genomic studies.			492
Arena issued patent for 5-HT2A receptor modulators.			946
Avigen's gene therapy technology acquired by Genzyme.			1267
BioMarin obtains United States patent.		Brief Article	74
Bios Agriculture obtains United States patent.			164
Biosite and Roche request stay of litigation.			187
Cepheid awarded patents for ultrasonic lysis and sample preparation technology.			358
Department of Health and Human Services obtains United States patent.			146
Dow AgroSciences prevails in patent dispute over canola oil.			577
Dow Chemical obtains United States patent.			88
EntreMed to acquire Miikana - acquisition strengthens oncology pipeline.			797
European patent issued to Bavarian Nordic A/S on vaccine vector.			414
Exelixis signs commercial license for the production of paclitaxel and taxane intermediates from plant cell culture.			604
Expiry of polymerase chain reaction patent offers exciting growth opportunities for nucleic acid purification and amplification technologies.			882
Genetics Institute obtains United States patent.			37
HemoCue defends its hemoglobin patent against EKF and Stanbio.		Brief Article	157
Inhibitex obtains United States patent.			157
Introgen reports advances in the development of oncolytic viruses for cancer treatment.			436
Japan Science and Technology obtains United States patent.		Brief Article	116
Lexicon Genetics achieves milestones in Genentech alliance.			508
LifeStem contracts with Solana to exclusively bank adult stem cells.			570
Merck Patent GmbH obtains United States patent.			89
Michigan Technological University obtains United States patent.			26
Millenium obtains United States patent.			109
Nabi Biopharmaceuticals updates progress of its Gram-positive infections portfolio.			628
Nanogen expands patent portfolio in genetic analysis technologies.			428
Nuvelo obtains United States patent.		Brief Article	84
Pharmion and GPC Biotech announce partnering agreement for prostate cancer treatment.			1322
PreMD comments on AtheroGenics' athersclerosis commercialization agreement.			300
Provectus to receive fifth medical device patent - plans to license.			283
Ravgen obtains United States patent.		Brief Article	100
United States International Trade Commission to investigate patent infringement in the importation of medical devices by Resonant.			423
University of Florida obtains United States patent.		Brief Article	95
University of Pennsylvania obtains United States patent.		Brief Article	107